(Q33962777)

30 July 2017

1 reference

title

ErbB2 activation and signal transduction in normal and malignant mammary cells (English)

1 reference

30 July 2017

Hynes NE

1

1 reference

30 July 2017

publication date

1 April 1996

1 reference

Journal of Mammary Gland Biology and Neoplasia

30 July 2017

published in

1 reference

30 July 2017

volume

1

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

199-206

1 reference

The cellular response to neuregulins is governed by complex interactions of the erbB receptor family

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02013643

Oncogenic activation of p185neu stimulates tyrosine phosphorylation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013643

Epidermal growth factor receptor, but not c-erbB-2, activation prevents lactogenic hormone induction of the beta-casein gene in mouse mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013643

Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013643

Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013643

Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013643

p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013643

Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013643

c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer

21 January 2018

1 reference

12 December 2020

Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2.

1 reference

12 December 2020

Neu and its ligands: from an oncogene to neural factors

1 reference

12 December 2020

Absence of activating transmembrane mutations in the c-erbB-2 proto-oncogene in human breast cancer

1 reference

12 December 2020

Amplification, overexpression, and rearrangement of the erbB-2 protooncogene in primary human stomach carcinomas.

1 reference

12 December 2020

Medullary carcinoma is associated with expression of intercellular adhesion molecule-1. Implication to its morphology and its clinical behavior

1 reference

12 December 2020

erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells

1 reference

12 December 2020

The c-erbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: A paradigm for the development of other macromolecular markers-A review

1 reference

12 December 2020

Intracellular single-chain antibody directed against erbB2 down-regulates cell surface erbB2 and exhibits a selective anti-proliferative effect in erbB2 overexpressing cancer cell lines

1 reference

12 December 2020

The mitogen-activated protein kinase signal transduction pathway

1 reference

12 December 2020

Oncogene amplification and prognosis in breast cancer: Relationship with systemic treatment

1 reference

12 December 2020

The biology of erbB-2/neu/HER-2 and its role in cancer

1 reference

12 December 2020

Identification of autophosphorylation sites of HER2/neu

1 reference

12 December 2020

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

12 December 2020

Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies

1 reference

12 December 2020

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

12 December 2020

Intracellular expression of single chain antibodies reverts ErbB-2 transformation.

1 reference

12 December 2020

Signal transduction by receptors with tyrosine kinase activity

1 reference

12 December 2020

EGF-stimulated tyrosine phosphorylation of p185neu: a potential model for receptor interactions

1 reference

12 December 2020

Intracellular expression of a single-chain antibody directed to the EGFR leads to growth inhibition of tumor cells

1 reference

12 December 2020

A single autophosphorylation site confers oncogenicity to the Neu/ErbB-2 receptor and enables coupling to the MAP kinase pathway

1 reference

12 December 2020

Neu differentiation factor (heregulin) induces expression of intercellular adhesion molecule 1: implications for mammary tumors

1 reference

12 December 2020

Src phosphorylation of the epidermal growth factor receptor at novel sites mediates receptor interaction with Src and P85 alpha

1 reference

12 December 2020

Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland

1 reference

12 December 2020

Intermolecular association and trans-phosphorylation of different neu-kinase forms permit SH2-dependent signaling and oncogenic transformation

1 reference

12 December 2020

Intermolecular association of the p185neu protein and EGF receptor modulates EGF receptor function

1 reference

12 December 2020

Expression and functional properties of transforming growth factor alpha and epidermal growth factor during mouse mammary gland ductal morphogenesis

1 reference

12 December 2020

Activation of the Ras signalling pathway in human breast cancer cells overexpressing erbB-2

1 reference

12 December 2020

Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin

1 reference

12 December 2020

Prevention of breast tumour development in vivo by downregulation of the p185neureceptor

1 reference

12 December 2020

Activation state-specific monoclonal antibody detects tyrosine phosphorylated p185neu/erbB-2 in a subset of human breast tumors overexpressing this receptor

1 reference

12 December 2020

PDGF- and insulin-dependent pp70S6k activation mediated by phosphatidylinositol-3-OH kinase

1 reference

12 December 2020

Ductal morphogenesis in the mouse mammary gland: evidence supporting a role for epidermal growth factor

1 reference

12 December 2020

Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185.

1 reference

12 December 2020

Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading.

1 reference

12 December 2020

SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins

1 reference

12 December 2020

SH2 domains recognize specific phosphopeptide sequences

1 reference

12 December 2020

Growth factor and sex steroid interactions in breast cancer

1 reference

12 December 2020

ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer

1 reference

12 December 2020

Heregulin induces tyrosine phosphorylation of HER4/p180erbB4

1 reference

12 December 2020

Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts

1 reference

12 December 2020

ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1, and RSK

1 reference

12 December 2020

p185neu is phosphorylated on tyrosine in human primary breast tumors which overexpress neu/erbB-2

1 reference

12 December 2020

Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product.

1 reference

12 December 2020

Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-beta

1 reference

12 December 2020

Neu differentiation factor/heregulin modulates growth and differentiation of HC11 mammary epithelial cells

1 reference

12 December 2020

Epidermal growth factor-related peptides and their receptors in human malignancies

1 reference

12 December 2020

Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities

1 reference

12 December 2020

Identification of heregulin, a specific activator of p185erbB2

1 reference

12 December 2020

Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas

1 reference

12 December 2020

An alternative to SH2 domains for binding tyrosine-phosphorylated proteins

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02013643

1 reference

release_dbiwta3qd5euth2f74ejhteuya

30 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dbiwta3qd5euth2f74ejhteuya

24 November 2022

mapped directly with Wikidata item

1 reference